| Hoffman La Roche and Smithkline Beecham Plc (UK) applications for Saquinavir and Rogiglitazone Maleate respectively have also been turned down by the Indian patent office. |
| Applications of Bayer for moxifloxacin hydrochloride, Schering Plough Corporation's US peg-interferon-alpha, Nicholas Piramal and Council of Scientific and Industrial Research Bulaquine and Cholroquine (anti malaria) are pending with the Indian patent office. |
| Eli Lilly's application for EMR for tadafil tablet is also pending with the government which is also yet to clear Panacea Biotech's application for nimesulide injection, sources said. |
| The patent office has, however, granted EMR to United Phosphorous for syneqistic fungicidal composition, Novartis (Wwitzerland) for imatinib mesilate and Wockhardt for nadifloxacin cream. |
Top Section
Explore Business Standard